Treatment dynamics of bone‐targeting agents among men with bone metastases from prostate cancer in the United States
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4360
Abstract: To examine the dynamics of treatment with 2 bone‐targeting agents (BTAs)—denosumab and zoledronic acid—among men with bone metastases from prostate cancer. read more here.
Keywords: bone targeting; bone metastases; metastases prostate; targeting agents ... See more keywords
Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-017-2460-6
Abstract: Intracranial metastasis from prostate cancer is rare. As treatment of castration-resistant prostate cancer improves, the incidence of men with intracranial metastasis from prostate cancer is increasing. Radiation therapy for treatment of intracranial metastasis from prostate… read more here.
Keywords: metastases prostate; prostate cancer; intracranial metastases; cancer ... See more keywords
Bone metastases in prostate cancer – Gallium-68–labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography – the better tracer?
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001621
Abstract: Objective The objective was to assess the roles of 68Ga-PSMA PET/CT and 18F-NaF PET/CT in evaluation of skeletal metastatic lesions in prostate cancer. Methods Two hundred consecutive prostate cancer patients who had undergone 68Ga-PSMA PET/CT… read more here.
Keywords: metastases prostate; pet; prostate cancer; 68ga psma ... See more keywords
Peritoneal Metastases From Prostate Carcinoma Treated With 177Lu-PSMA-I&T.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004577
Abstract: ABSTRACT A 71-year-old man was referred for 177Lu-PSMA therapy. He had metastatic castration-resistant prostate cancer, progressive on several treatment lines, with current PSA 260 μg/L and deteriorating condition. CT showed ascites with omental and peritoneal… read more here.
Keywords: carcinoma treated; peritoneal metastases; 177lu psma; metastases prostate ... See more keywords
Metastases in Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Cold Spring Harbor perspectives in medicine"
DOI: 10.1101/cshperspect.a033688
Abstract: Prostate cancer (PCa) prognosis and clinical outcome is directly dependent on metastatic occurrence. The bone microenvironment is a favorable metastatic niche. Different biological processes have been suggested to contribute to the osteotropism of PCa such… read more here.
Keywords: seed; metastases prostate; prostate cancer; pca ... See more keywords
Clinicopathological predictors of bone metastases in prostate cancer patients.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e17520
Abstract: e17520Background: To determine if there is association between the clinical-pathological characteristics and the development of bone metastases in patients with prostate cancer treated in Oncosalud... read more here.
Keywords: bone metastases; metastases prostate; prostate cancer; clinicopathological predictors ... See more keywords
Case Report: 18F-PSMA PET/CT May Improve the Clinical Management of Penile Metastases From Prostate Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.683343
Abstract: Metastases from prostate cancer (PCa) to the penis are extremely rare, and few case reports exist in the literature. Because most patients usually present with multiple distant metastases at diagnosis, the prognosis is very poor.… read more here.
Keywords: psma pet; metastases prostate; penile metastases; prostate cancer ... See more keywords
Cerebellar Metastases from Prostate Cancer Detected by PET/CT with 18F-Choline
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Imaging and Radionuclide Therapy"
DOI: 10.4274/mirt.galenos.2021.59672
Abstract: A 76-year-old male, previously submitted enucleation renal-cell carcinoma (pT1) and prostatectomy for prostate cancer (Gleason score 3+5, pT3b pN0 pMx), was submitted to positron emission/computed tomography (PET/CT) with 18F-choline for restaging due to raised levels… read more here.
Keywords: prostate cancer; metastases prostate; pet 18f; 18f choline ... See more keywords